Tirva Robert L.'s Form 4 filing
DNA X, Inc. (SONM) · filed Jun 13, 2022
- Accession no.
- 0000899243-22-022227
- Filed
- Jun 13, 2022
- Trade date
- Jun 10, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.61K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tirva Robert L.CIK 0001438223 | Officer (President, CFO and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 | Common Stock | SSaleDisposed | −4,493 | $0.58 | −$2,605.94 | 334,885 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.